WILLIAM F. RENCHER, Ph.D., R.Ph. Director, Product
Development,
CONRAD
Assistant Professor, Dept. of Obstetrics and
Gynecology, EVMS (703) 276-3906 brencher@conrad.org
Dr. Rencher joined CONRAD in 1997. He
provides expertise and leadership in product development of
microbicide and contraceptive drugs and devices under
development by CONRAD or our collaborators. He and his
staff facilitate development of time efficient plans and their
implementation by working closely with investigators,
industrial partners, subcontractors and FDA. His group
coordinates technology transfer, analytical method, drug
synthesis and formulation development, clinical supply
production and toxicology studies. He reviews and if
necessary writes the CMC and Pharm/Tox sections of regulatory
documents. As a member of CONRAD's Pre-Clinical Team, he
solicits and reviews potential microbicides and contraceptive
candidates. He is the project manager for the
development of cellulose sulfate, now in Phase III clinical
studies, and technical monitor for several other drug
candidates with microbicidal and contraceptive
properties. Dr. Rencher received his B.S. in Pharmacy in
1982 and his Ph.D. in Pharmaceutical Sciences in 1987 from the
University of Kentucky. Dr. Rencher has over ten years
of industry experience in the areas of drug development,
bioavailability testing, project management, and development
of laboratory and Good Manufacturing Practice (GMP)-compliant
facilities. He is well versed in cGMP regulations and
has co-written seveal Investigational New Drug applications,
New Drug Applications, and Investigational Device
Exemptions. He has abeen a co-author for journal
articles on preclinical evaluation of microbicides and
contraceptives and served as editor for Vaginal
Microbicides Formulations Workshop, proceedings from the
meeting he organized.
